Virpax Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Virpax Pharmaceuticals generated cash of -$9,853,772, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore -$9,853,772.
Cash Flow
| 2018 | -1.79M | 0 | 1.67M |
|---|---|---|---|
| 2019 | -1.13M | 0 | 1.12M |
| 2020 | -1.38M | 0 | 1.39M |
| 2021 | -14.54M | 0 | 51.32M |
| 2022 | -17.84M | 0 | 0 |
| 2023 | -9.85M | 0 | 0 |
VRPX Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 18.99M | 36.84M | 54.79K | 41.53K | 48.37K | 173.24K |
Operating activities | ||||||
Net income | -15.18M | -21.65M | -12.05M | -4.33M | -3.30M | -2.64M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 544.77K | 745.03K | 974.23K | 1.47M | 678.14K | 0 |
| Deferred income tax benefit | 544.77K | 745.03K | 974.23K | 1.47M | 678.14K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | -993.10K | -686.77K | 1.34M | 923.94K | 454.50K |
Cash generated by operating activities | -9.85M | -17.84M | -14.54M | -1.38M | -1.13M | -1.79M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 | 0 |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 58.02M | 1.37M | 625K | 1.12M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -1.60M | -21.22K | 500K | 0 |
Cash used in financing activities | 0 | 0 | 51.32M | 1.39M | 1.12M | 1.67M |
Net Change In Cash | -9.85M | -17.84M | 36.78M | 13.26K | -6.83K | -124.87K |
Cash at end of period | 9.14M | 18.99M | 36.84M | 54.79K | 41.53K | 48.37K |
| Data source | Data source | Data source | Data source |